US HB2026 | 2017-2018 | 115th Congress
Status
Spectrum: Partisan Bill (Republican 1-0)
Status: Introduced on April 6 2017 - 25% progression, died in chamber
Action: 2018-01-17 - Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 6 2017 - 25% progression, died in chamber
Action: 2018-01-17 - Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 .
Text: Latest bill text (Introduced) [PDF]
Summary
Pharmaceutical Information Exchange Act This bill amends the Federal Food, Drug, and Cosmetic Act to allow information about a new investigational medication or the investigational use of a medication approved by the Food and Drug Administration to be provided to health care entities if the information is based on reliable scientific evidence.
Title
Pharmaceutical Information Exchange Act
Sponsors
| Rep. Brett Guthrie [R-KY] |
History
| Date | Chamber | Action |
|---|---|---|
| 2018-01-17 | House | Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 18 - 14 . |
| 2018-01-17 | House | Subcommittee Consideration and Mark-up Session Held. |
| 2017-04-07 | House | Referred to the Subcommittee on Health. |
| 2017-04-06 | House | Referred to the House Committee on Energy and Commerce. |
| 2017-04-06 | House | Introduced in House |
Subjects
Drug safety, medical device, and laboratory regulation
Fraud offenses and financial crimes
Health
Health information and medical records
Medical research
Fraud offenses and financial crimes
Health
Health information and medical records
Medical research
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/115th-congress/house-bill/2026/all-info |
| Text | https://www.congress.gov/115/bills/hr2026/BILLS-115hr2026ih.pdf |
